Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (E… (NCT07351331) | Clinical Trial Compass
CompletedNot Applicable
Intratissue Electrolysis (EPI) is Effective in Deactivating Myofascial Trigger Points (MTrPs). (EPIEMG)
Spain40 participantsStarted 2024-11-15
Plain-language summary
Invasive physiotherapy techniques, such as Intratissue Percutaneous Electroly-sis (IPE), have numerous beneficial effects depending on the pathology being treated, in-cluding the deactivation of myofascial trigger points (MTP) caused by myofascial pain syndrome (MPS).
The objectives are (1) evaluate the effectiveness of low intesity IPE treatment com-pared to DN on the shortening of FHB in patients with MPS, in 4 and 12 weeks evaluation, (2) assess the distribution of plantar pressures after the interventions and (3) evaluate the modification of FHB activation following the interventions.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* subjects with ages between 18 and 65 years,
* hypersensitive spot within a taut band in FHB muscle.
* pain upon stimulation of the MTP.
* painful limit to the full range of motion
Exclusion Criteria:
* subjets who had bilateral LTP present.
* who have had a lower limb injury or surgery within the last 6 months.
* subjectss with active pathologies at the time of measurement in the lower limb.
* subjectss with cognitive impairment.
* subjectss with belonephobia or contraindications for the use of needles (oral anticoagulant therapy).
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
mean pressures (MP)
Timeframe: It was measured at the start of the protocol in week 1, in week 4 and in week 12.
2
maximum pressures (PMáx)
Timeframe: It was measured at the start of the protocol in week 1, in week 4 and in week 12.
3
maximal voluntary contraction (MVC)
Timeframe: It was measured at the start of the protocol in week 1, in week 4 and in week 12.
4
dynamic muscular activation of the FHB
Timeframe: It was measured at the start of the protocol in week 1, in week 4 and in week 12.